| Dr Dingchao He, MD | |
|
6323 Georgia Ave Nw Ste 101, Washington, DC 20011 | |
| (202) 795-3022 | |
| (202) 290-1539 |
| Full Name | Dr Dingchao He |
|---|---|
| Gender | Male |
| Speciality | General Surgery |
| Experience | 40 Years |
| Location | 6323 Georgia Ave Nw Ste 101, Washington, District Of Columbia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1932526407 | NPI | - | NPPES |
| 075457900 | Medicaid | MD | |
| 084518100 | Medicaid | DC |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Usa Vein Clinics Of District Of Columbia Llc | 2860794401 | 2 |
| Usa Vein Clinics Of Chantilly Llc | 6406284462 | 3 |
News Archive
"Freshman Sen. Marco Rubio is becoming an increasingly critical and hawkish voice on the Obama administration's foreign policy, but he is actually a supporter of U.S. foreign assistance programs and made the case for maintaining this funding to his constituents last week," Foreign Policy's "The Cable" blog writes.
Officials worry that people with no insurance will be drawn in by questionable health insurance plans. ABC News reports: The "[h]ealth care overhaul is stalled, resulting in a proliferation of plans that don't fully protect people, officials said. Watchdogs worry about two kinds of plans in particular."
NuPathe Inc., a specialty pharmaceutical company developing innovative products for the treatment of neurological and psychiatric diseases, today announced data from the pivotal Phase III trial of Zelrix™, a novel transdermal patch in clinical development for the treatment of acute migraine. Zelrix combines NuPathe's proprietary SmartRelief™ iontophoretic transdermal technology with sumatriptan, the most prescribed treatment for acute migraine in the United States.
Investigators at Case Western Reserve University School of Medicine received a $6.75 million Program Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to study the role of innate immunity in inflammatory bowel disease.
› Verified 2 days ago
| Entity Name | Usa Vein Clinics Of District Of Columbia Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710359211 PECOS PAC ID: 2860794401 Enrollment ID: O20160919002665 |
News Archive
"Freshman Sen. Marco Rubio is becoming an increasingly critical and hawkish voice on the Obama administration's foreign policy, but he is actually a supporter of U.S. foreign assistance programs and made the case for maintaining this funding to his constituents last week," Foreign Policy's "The Cable" blog writes.
Officials worry that people with no insurance will be drawn in by questionable health insurance plans. ABC News reports: The "[h]ealth care overhaul is stalled, resulting in a proliferation of plans that don't fully protect people, officials said. Watchdogs worry about two kinds of plans in particular."
NuPathe Inc., a specialty pharmaceutical company developing innovative products for the treatment of neurological and psychiatric diseases, today announced data from the pivotal Phase III trial of Zelrix™, a novel transdermal patch in clinical development for the treatment of acute migraine. Zelrix combines NuPathe's proprietary SmartRelief™ iontophoretic transdermal technology with sumatriptan, the most prescribed treatment for acute migraine in the United States.
Investigators at Case Western Reserve University School of Medicine received a $6.75 million Program Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to study the role of innate immunity in inflammatory bowel disease.
› Verified 2 days ago
| Entity Name | Usa Vein Clinics Of Chantilly Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1124670930 PECOS PAC ID: 6406284462 Enrollment ID: O20200325001981 |
News Archive
"Freshman Sen. Marco Rubio is becoming an increasingly critical and hawkish voice on the Obama administration's foreign policy, but he is actually a supporter of U.S. foreign assistance programs and made the case for maintaining this funding to his constituents last week," Foreign Policy's "The Cable" blog writes.
Officials worry that people with no insurance will be drawn in by questionable health insurance plans. ABC News reports: The "[h]ealth care overhaul is stalled, resulting in a proliferation of plans that don't fully protect people, officials said. Watchdogs worry about two kinds of plans in particular."
NuPathe Inc., a specialty pharmaceutical company developing innovative products for the treatment of neurological and psychiatric diseases, today announced data from the pivotal Phase III trial of Zelrix™, a novel transdermal patch in clinical development for the treatment of acute migraine. Zelrix combines NuPathe's proprietary SmartRelief™ iontophoretic transdermal technology with sumatriptan, the most prescribed treatment for acute migraine in the United States.
Investigators at Case Western Reserve University School of Medicine received a $6.75 million Program Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to study the role of innate immunity in inflammatory bowel disease.
› Verified 2 days ago
| Entity Name | Usa Vascular Centers Of District Of Columbia Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1841802857 PECOS PAC ID: 0941677413 Enrollment ID: O20221114001102 |
News Archive
"Freshman Sen. Marco Rubio is becoming an increasingly critical and hawkish voice on the Obama administration's foreign policy, but he is actually a supporter of U.S. foreign assistance programs and made the case for maintaining this funding to his constituents last week," Foreign Policy's "The Cable" blog writes.
Officials worry that people with no insurance will be drawn in by questionable health insurance plans. ABC News reports: The "[h]ealth care overhaul is stalled, resulting in a proliferation of plans that don't fully protect people, officials said. Watchdogs worry about two kinds of plans in particular."
NuPathe Inc., a specialty pharmaceutical company developing innovative products for the treatment of neurological and psychiatric diseases, today announced data from the pivotal Phase III trial of Zelrix™, a novel transdermal patch in clinical development for the treatment of acute migraine. Zelrix combines NuPathe's proprietary SmartRelief™ iontophoretic transdermal technology with sumatriptan, the most prescribed treatment for acute migraine in the United States.
Investigators at Case Western Reserve University School of Medicine received a $6.75 million Program Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to study the role of innate immunity in inflammatory bowel disease.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Dingchao He, MD Po Box 1602, Northbrook, IL 60065-1602 Ph: (847) 593-8460 | Dr Dingchao He, MD 6323 Georgia Ave Nw Ste 101, Washington, DC 20011 Ph: (202) 795-3022 |
News Archive
"Freshman Sen. Marco Rubio is becoming an increasingly critical and hawkish voice on the Obama administration's foreign policy, but he is actually a supporter of U.S. foreign assistance programs and made the case for maintaining this funding to his constituents last week," Foreign Policy's "The Cable" blog writes.
Officials worry that people with no insurance will be drawn in by questionable health insurance plans. ABC News reports: The "[h]ealth care overhaul is stalled, resulting in a proliferation of plans that don't fully protect people, officials said. Watchdogs worry about two kinds of plans in particular."
NuPathe Inc., a specialty pharmaceutical company developing innovative products for the treatment of neurological and psychiatric diseases, today announced data from the pivotal Phase III trial of Zelrix™, a novel transdermal patch in clinical development for the treatment of acute migraine. Zelrix combines NuPathe's proprietary SmartRelief™ iontophoretic transdermal technology with sumatriptan, the most prescribed treatment for acute migraine in the United States.
Investigators at Case Western Reserve University School of Medicine received a $6.75 million Program Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to study the role of innate immunity in inflammatory bowel disease.
› Verified 2 days ago
Dr. Andrea Badillo, MD Surgery Medicare: Medicare Enrolled Practice Location: 111 Michigan Ave Nw, Washington, DC 20010 Phone: 202-476-2451 Fax: 202-476-4174 | |
Jerome Alain Byam, Surgery Medicare: Accepting Medicare Assignments Practice Location: 1310 Southern Ave Se, Washington, DC 20032 Phone: 202-574-6000 | |
Dr. Steven Macht, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 2021 K St Nw, #217, Washington, DC 20006 Phone: 202-887-8120 Fax: 202-887-8288 | |
Earl Hodin, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 111 Michigan Ave Nw, Washington, DC 20010 Phone: 202-884-2151 | |
Dr. Brandon W Propper, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 2150 Pennsylvania Ave Nw, Washington, DC 20037 Phone: 202-741-3210 | |
David H Song, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 3800 Reservoir Rd Nw, Phc Building, First Floor, Washington, DC 20007 Phone: 202-444-8751 Fax: 202-444-7204 | |
Melissa Martinez Anastacio, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 110 Irving St Nw, Room 4b42, Washington, DC 20010 Phone: 202-877-7259 Fax: 202-877-7258 |